title: Concise drug review: azacitidine and decitabine.
authors.affiliation: Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
authors.forename: Ellen J B
authors.initials: EJ
authors.lastname: Derissen
authors.forename: Jos H
authors.initials: JH
authors.lastname: Beijnen
authors.forename: Jan H M
authors.initials: JH
authors.lastname: Schellens
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D001374:Azacitidine / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D017326:Clinical Trials, Phase III as Topic; D000077209:Decitabine; D017277:Drug Approval; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D015477:Leukemia, Myelomonocytic, Chronic / Q000188:drug therapy; D009190:Myelodysplastic Syndromes / Q000188:drug therapy
chemical_list: D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine
keywords: Azacitidine; DNA methyltransferase inhibitor; Decitabine; Drug profile; Hypomethylating drug